Prediction Tool
By Memorial Sloan-Kettering  |  Wednesday, January 25, 2012

Our ovarian cancer nomogram is a personalized tool that can help you and your doctor make important treatment decisions after surgery.

Finding
By Esther Napolitano, BS, Science Writer/Editor  |  Monday, January 23, 2012

Research has shown that children who have experienced a sunburn at an early age are at almost double the risk for developing melanoma in adulthood. Now, a new study led by Memorial Sloan-Kettering epidemiologist Stephen Dusza finds that most children do not regularly use sunscreen.

Pictured: Eric Pamer
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Friday, January 20, 2012

Infections are a common cause of complications in cancer patients. Now a Memorial Sloan-Kettering research team finds that a commonly prescribed antibiotic could increase susceptibility to a bacterial infection.

Pictured: Michael Quinlan
Patient Story
By Memorial Sloan-Kettering  |  Thursday, January 19, 2012

When actor Michael Quinlan was diagnosed with prostate cancer, he came to Memorial Sloan-Kettering to learn about treatment options from our multidisciplinary team of experts. After undergoing robot-assisted laparoscopic surgery, he remains cancer-free.

Pictured: Mark Bilsky, Eric Lis, Josh Yamada, and George Krol
Cancer Guide
By Memorial Sloan-Kettering  |  Tuesday, January 17, 2012

The Spine Tumor Center at Memorial Sloan-Kettering provides state-of-the-art diagnostic and treatment services for more than 1,500 people with primary or metastatic spine tumors each year.

Pictured: Michael Morris
In the Clinic
By Media Staff  |  Friday, January 13, 2012

Researchers at Memorial Sloan-Kettering have shown the usefulness of a scale called the Bone Scan Index (BSI) for determining whether some prostate cancer patients are responding to therapy.

Pictured: Major Trends in Modern Cancer Research Seminar
Video
By Memorial Sloan-Kettering  |  Thursday, January 12, 2012

Hundreds of high school students and teachers attended our sixth annual Major Trends in Modern Cancer Research seminar to learn about cutting-edge biomedical research and to engage with leading scientists.

Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens
Feature
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, December 28, 2011

Years of innovative research, technology development, and facility expansion at Memorial Sloan-Kettering have led to several new experimental treatments for people with cancer.

Pictured: Craig Thompson
Perspective
By Craig Thompson, MD, President and CEO  |  Friday, December 23, 2011

Since the signing of the National Cancer Act in 1971, tremendous progress has been made in preventing and treating cancer—though challenges remain.

Pictured: Blood donation
In the News
By Media Staff  |  Thursday, December 22, 2011

After signing up for the National Bone Marrow Registry “Be The Match,” a Montclair man was recently called to donate peripheral blood stem cells for a sick child. He was inspired to join the registry after an anonymous donor saved the life of his own son, who had received a bone marrow transplant.

Philanthropy
By Memorial Sloan-Kettering  |  Wednesday, December 21, 2011

As a tribute to Memorial Sloan-Kettering Board member Josephine “Josie” Robertson, Memorial Sloan-Kettering has joined with The Robertson Foundation to undertake two high-profile initiatives — the Josie Robertson Surgery Center and the Josie Robertson Investigators Program — made possible by a $50 million commitment from The Robertson Foundation.

Pictured: Hans-Guido Wendel
Profile
By Jim Stallard, MA, Writer/Editor  |  Tuesday, December 20, 2011

German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma.

Pictured: Nancy Lee
In the Clinic
By Eva Kiesler, PhD, Science Writer/Editor  |  Monday, December 19, 2011

People with cancer of the nasopharynx, an area behind the nose, may benefit from a new combination therapy, according to an international study led by Memorial Sloan-Kettering radiation oncologist Nancy Y. Lee.

Feature
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, December 15, 2011

Memorial Sloan-Kettering scientists, physicians, and administrators are developing and commercializing research discoveries to generate more-effective and affordable cancer treatments.

Honor
By Media Staff  |  Wednesday, December 14, 2011

Five Memorial Sloan-Kettering scientists have been appointed to a new research team dedicated to identifying targets for therapies to treat a certain form of melanoma.

Center News

Subscribe to Our E-newsletter

Get the latest information about cancer care.